A physician researcher discusses why primary care physicians do not participate in value-based payment models.
Richard Payerchin
Advertisement
Richard Payerchin is editor of Medical Economics.
Articles by Richard Payerchin
Rep. Greg Murphy, MD, discusses his bill to stop the planned Medicare reimbursement reduction.
Ferguson, who opposed ban of noncompetes, named to succeed Chair Khan; new commissioner Meador called for PBM regulations.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
Monthly report shows gains for hospitals, home health care services.
How is life different across the pond? UK babies can expect to live longer than newborn Americans.
The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.
Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.
The Commonwealth Fund compares United States with other developed nations.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.
‘Old guys are taking ER call’ as younger docs ponder medicine as a calling, or just a job.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
The clock is ticking for lawmakers to approve policies that could affect U.S. health care.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Institutional leaders want to standardize practices, but flexibility may be a key to keeping doctors.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Proposals would require more public data on prior authorization processes and whether those advance health equity.
Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
News reports state RFK Jr. could take aim at codes recommended by the American Medical Association.
Advertisement
Advertisement
Advertisement
Trending on Medical Economics
1
Missouri man sentenced in $174M genetic testing fraud; half of U.S. adults plan to try New Year’s diets; new transplant shows promise in aplastic anemia – Morning Medical Update
2
FDA grants Breakthrough Device status to Nephrodite's implantable continuous dialysis system
3
How to catchup on your retirement savings
4
Patients want fast access, familiar faces and in-person care
5
